Drug · DIN 02456214
TAGRISSO
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 19, 2016; first marketed July 19, 2016.
- Drug Identification Number (DIN)
- 02456214
- Company (DIN owner)
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Osimertinib L01EB04
- Class
- Human
- Record last updated
- May 21, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| OSIMERTINIB (OSIMERTINIB MESYLATE) | 40 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 5, 2016: NOC 18223New Drug Submission (NDS)
Other DINs named TAGRISSO
- DIN 02456222 · Marketed